Table 4.
Mediator | ΔNeurocognitive Performance | Adjustment for Mediator | DASH+WM vs UC | DASH+WM Sobel Test | DASH-A vs UC | DASH-A Sobel Test |
---|---|---|---|---|---|---|
EFML | ||||||
Δ weight, kg | −0.30‡ | Unadjusted | 0.35* | § | § | |
Adjusted | 0.46* | Z101= −0.62 | ||||
Δ peak V̇ O2, mL/kg per min | 0.19** | Unadjusted | 0.35* | § | § | |
Adjusted | 0.10† | Z101=2.14† | ||||
ΔSBP, mm Hg | −0.16† | Unadjusted | 0.35* | § | § | |
Adjusted | 0.26‡ | Z101=1.53 | ||||
Psychomotor speed | ||||||
Δweight, kg | −0.36† | Unadjusted | 0.26† | 0.23† | Z101=0.944 | |
Adjusted | −0.09 | Z101=2.21† | 0.20† | |||
Δpeak V̇O2, mL/kg per min | 0.13† | Unadjusted | 0.26† | 0.23† | Z101=0.72 | |
Adjusted | 0.10 | Z101=1.72‡ | 0.21† | |||
ΔSBP, mm Hg | −0.04 | Unadjusted | 0.26† | 0.23† | Z101=−0.13 | |
Adjusted | § | Z101=−0.13 | 0.23† |
Contrasts are adjusted for pretreatment neurocognitive performance, age, education, IMT, Framingham Stroke Risk Profile, and abdominal adiposity.
P<0.01.
P<0.05.
P<0.10.
Data show mediation analyses that were not conducted because either there was no main effect of treatment or changes in the mediating variable were not significantly related to neurocognitive outcomes.